BCO Fundamental Analysis - BOEING CO/THE

Fundamental Rating

Taking everything into account, BCO scores 1 out of 10 in our fundamental rating. BCO was compared to 49 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BCO have multiple concerns. BCO is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BCO has reported negative net income.

In the past year BCO has reported a negative cash flow from operations.

In the past 5 years BCO always reported negative net income.

The reported operating cash flow has been mixed in the past 5 years: BCO reported negative operating cash flow in multiple years.

1.2 Ratios

BCO has a Return On Assets of -6.78%. This is amonst the worse of the industry: BCO underperforms 87.76% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROIC	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BCO's Gross Margin of 1.10% is on the low side compared to the rest of the industry. BCO is outperformed by 89.80% of its industry peers.

The Profit Margin and Operating Margin are not available for BCO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.1%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.

BCO has more shares outstanding than it did 1 year ago.

BCO has more shares outstanding than it did 5 years ago.

BCO has a better debt/assets ratio than last year.

2.2 Solvency

BCO has an Altman-Z score of 1.16. This is a bad value and indicates that BCO is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.16, BCO is not doing good in the industry: 85.71% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	1.16

ROIC/WACCN/A

WACC8.96%

2.3 Liquidity

A Current Ratio of 1.18 indicates that BCO should not have too much problems paying its short term obligations.

BCO has a Current ratio (1.18) which is in line with its industry peers.

A Quick Ratio of 0.38 indicates that BCO may have some problems paying its short term obligations.

BCO has a Quick ratio of 0.38. This is amonst the worse of the industry: BCO underperforms 91.84% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.18
Quick Ratio	0.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for BCO have decreased by -1.07% in the last year.

The Revenue has grown by 10.18% in the past year. This is quite good.

BCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

3.2 Future

The Earnings Per Share is expected to grow by 20.77% on average over the next years. This is a very strong growth

BCO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.75% yearly.

EPS Next Y52.52%

EPS Next 2Y45.1%

EPS Next 3Y31.85%

EPS Next 5Y20.77%

Revenue Next Year30.21%

Revenue Next 2Y19.8%

Revenue Next 3Y17.46%

Revenue Next 5Y14.75%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 94.58, the valuation of BCO can be described as expensive.

77.55% of the companies in the same industry are cheaper than BCO, based on the Price/Forward Earnings ratio.

BCO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.96.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	94.58

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BCO does not grow enough to justify the current Price/Earnings ratio.

BCO's earnings are expected to grow with 31.85% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y45.1%

EPS Next 3Y31.85%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BCO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BOEING CO/THE

FRA:BCO (12/12/2025, 5:29:46 PM)

173.44

+2.72 (+1.59%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)10-29 2025-10-29/bmo

Earnings (Next)01-26 2026-01-26/amc

Inst Owners73.97%

Inst Owner ChangeN/A

Ins Owners0.03%

Ins Owner ChangeN/A

Market Cap131.83B

Revenue(TTM)80.76B

Net Income(TTM)-10.17B

Analysts83.43

Price Target216.87 (25.04%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-19.63%

Min EPS beat(2)-57.93%

Max EPS beat(2)18.67%

EPS beat(4)2

Avg EPS beat(4)-16.78%

Min EPS beat(4)-91.07%

Max EPS beat(4)63.2%

EPS beat(8)5

Avg EPS beat(8)-3.37%

EPS beat(12)6

Avg EPS beat(12)-66.45%

EPS beat(16)6

Avg EPS beat(16)-757.66%

Revenue beat(2)2

Avg Revenue beat(2)1.97%

Min Revenue beat(2)1.11%

Max Revenue beat(2)2.82%

Revenue beat(4)2

Avg Revenue beat(4)-1.87%

Min Revenue beat(4)-8.71%

Max Revenue beat(4)2.82%

Revenue beat(8)3

Avg Revenue beat(8)-1.85%

Revenue beat(12)4

Avg Revenue beat(12)-1.59%

Revenue beat(16)4

Avg Revenue beat(16)-4.27%

PT rev (1m)-4.38%

PT rev (3m)-3.52%

EPS NQ rev (1m)-57.49%

EPS NQ rev (3m)-811.04%

EPS NY rev (1m)-12.42%

EPS NY rev (3m)-403.98%

Revenue NQ rev (1m)-0.96%

Revenue NQ rev (3m)-1.34%

Revenue NY rev (1m)0.15%

Revenue NY rev (3m)2.19%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	94.58
P/S	1.91
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-12.89

EYN/A

EPS(NY)1.83

Fwd EY1.06%

FCF(TTM)-7.13

FCFYN/A

OCF(TTM)-4.17

OCFYN/A

SpS90.7

BVpS-9.27

TBVpS-19.12

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.1%
FCFM	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	136.76%
Cap/Sales	3.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.18
Quick Ratio	0.38
Altman-Z	1.16

F-Score4

WACC8.96%

ROIC/WACCN/A

Cap/Depr(3y)90.02%

Cap/Depr(5y)74.76%

Cap/Sales(3y)2.43%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

EPS Next Y52.52%

EPS Next 2Y45.1%

EPS Next 3Y31.85%

EPS Next 5Y20.77%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

Revenue Next Year30.21%

Revenue Next 2Y19.8%

Revenue Next 3Y17.46%

Revenue Next 5Y14.75%

EBIT growth 1Y-25.36%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year76.34%

EBIT Next 3Y48.22%

EBIT Next 5Y32.37%

FCF growth 1Y-237.62%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.56%

OCF growth 3YN/A

OCF growth 5YN/A

BOEING CO/THE / BCO.DE FAQ

What is the fundamental rating for BCO stock?

ChartMill assigns a fundamental rating of 1 / 10 to BCO.DE.

What is the valuation status of BOEING CO/THE (BCO.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BCO.DE). This can be considered as Overvalued.

How profitable is BOEING CO/THE (BCO.DE) stock?

BOEING CO/THE (BCO.DE) has a profitability rating of 0 / 10.

What is the expected EPS growth for BOEING CO/THE (BCO.DE) stock?

The Earnings per Share (EPS) of BOEING CO/THE (BCO.DE) is expected to grow by 52.52% in the next year.

BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BOEING CO/THE / BCO.DE FAQ

What is the fundamental rating for BCO stock?

What is the valuation status of BOEING CO/THE (BCO.DE) stock?

How profitable is BOEING CO/THE (BCO.DE) stock?

What is the expected EPS growth for BOEING CO/THE (BCO.DE) stock?